$35.59
0.120.34%
At close: -
$35.59
0.000.00%
After Hours: Jul 18, 4:34 PM EDT
Comments
Loading...
Royalty Pharma Earnings Estimates, EPS & Revenue | NASDAQ:RPRX | Benzinga
Royalty Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 6
EPS Estimate
$1.085
Quarterly Revenue Estimate
$666.75M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.26B
Analyze the earnings history of Royalty Pharma using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
RPRX | Royalty Pharma | $0.96 | $1.08 | — | — | $537.00M | $666.75M | — | — | 08/06/2025 | |
RPRX | Royalty Pharma | $0.98 | $1.59 | $1.06 | 11.26% | $568.00M | $705.34M | $568.00M | -21.62% | 05/08/2025 | |
RPRX | Royalty Pharma | $1.15 | $1.05 | $1.16 | 10.48% | $596.00M | $678.89M | $594.00M | -20.12% | 02/11/2025 | |
RPRX | Royalty Pharma | $0.79 | $0.93 | $1.04 | 11.83% | $536.00M | $696.10M | $565.00M | -18.83% | 11/06/2024 | |
RPRX | Royalty Pharma | $0.84 | $0.99 | $0.96 | -3.03% | $538.00M | $628.26M | $537.00M | -14.53% | 08/08/2024 | |
RPRX | Royalty Pharma | $1.60 | $0.99 | $0.98 | -1.01% | $684.00M | $663.22M | $568.00M | -14.36% | 05/09/2024 | |
RPRX | Royalty Pharma | $1.56 | $0.99 | $1.15 | 16.16% | $566.00M | $673.65M | $596.00M | -11.53% | 02/15/2024 | |
RPRX | Royalty Pharma | $0.32 | $0.77 | $0.79 | 2.60% | $573.46M | $614.36M | $536.00M | -12.75% | 11/08/2023 | |
RPRX | Royalty Pharma | $0.70 | $0.83 | $0.84 | 1.20% | $535.96M | $538.52M | $538.00M | -0.10% | 08/08/2023 | |
RPRX | Royalty Pharma | $0.60 | $1.27 | $1.60 | 25.98% | $562.00M | $852.90M | $684.00M | -19.80% | 05/09/2023 | |
RPRX | Royalty Pharma | $0.80 | $1.52 | $1.56 | 2.63% | $576.00M | $937.93M | $566.00M | -39.65% | 02/15/2023 | |
RPRX | Royalty Pharma | $0.24 | $0.71 | $0.32 | -54.93% | $585.77M | $585.37M | $573.46M | -2.03% | 11/08/2022 | |
RPRX | Royalty Pharma | $0.73 | $0.78 | $0.70 | -10.26% | $555.00M | $542.18M | $535.96M | -1.15% | 08/04/2022 | |
RPRX | Royalty Pharma | $0.67 | $0.73 | $0.60 | -17.81% | $573.03M | $599.76M | $562.00M | -6.30% | 05/05/2022 | |
RPRX | Royalty Pharma | $0.27 | $0.77 | $0.80 | 3.90% | $572.00M | $556.79M | $576.00M | 3.45% | 02/15/2022 | |
RPRX | Royalty Pharma | $0.48 | — | $0.24 | — | $538.00M | $578.20M | $585.77M | 1.31% | 11/10/2021 | |
RPRX | Royalty Pharma | $0.99 | $0.69 | $0.73 | 5.80% | $511.00M | $483.42M | $555.00M | 14.81% | 08/11/2021 | |
RPRX | Royalty Pharma | — | $0.65 | $0.18 | -72.31% | — | $509.70M | $573.03M | 12.42% | 05/11/2021 | |
RPRX | Royalty Pharma | — | $0.69 | $0.27 | -60.87% | — | $480.71M | $572.00M | 18.99% | 02/17/2021 | |
RPRX | Royalty Pharma | — | $0.64 | $0.48 | -25.00% | — | $462.45M | $538.00M | 16.34% | 11/10/2020 | |
RPRX | Royalty Pharma | — | $0.61 | $0.99 | 62.30% | — | $468.96M | $511.00M | 8.96% | 08/12/2020 |
Royalty Pharma (RPRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $1.06 | $1.59 | 11.3 % |
| Q4 | 2025-02-11 | $1.16 | $1.05 | 10.5 % |
| Q3 | 2024-11-06 | $1.04 | $0.93 | 11.8 % |
| Q2 | 2024-08-08 | $0.96 | $0.99 | -3.03 % |
Royalty Pharma (RPRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $568.00M | $705.34M | -21.6 % |
| Q4 | 2025-02-11 | $594.00M | $678.89M | -20.1 % |
| Q3 | 2024-11-06 | $565.00M | $696.10M | -18.8 % |
| Q2 | 2024-08-08 | $537.00M | $628.27M | -14.5 % |
FAQ
When is Royalty Pharma (NASDAQ:RPRX) reporting earnings?
Royalty Pharma (RPRX) is scheduled to report earnings on August 6, 2025. The last reported earnings were for reported on May 8, 2025 for Q1.
What were the latest earnings per share (EPS) for Royalty Pharma (NASDAQ:RPRX)?
The Actual EPS was $1.06, which missed the estimate of $1.59.
What were Royalty Pharma’s (NASDAQ:RPRX) revenues?
The Actual Revenue was $568M, which missed the estimate of $705.3M.
Browse earnings estimates, EPS, and revenue on all stocks.
